Live feed
Filing
SC 13G
SC 13G0001683168-24-007319·Deutsch Peter E.
Schedule 13G ownership disclosure
Spyre Therapeutics Inc
Security class unavailable · CUSIP: 00773J202
Event date: 2024-10-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001683168-24-007319
- Form type
- SC 13G
- Filer
- Deutsch Peter E.
- CIK
- CIK 1998610
- Filed
- Oct 23, 2024
- Reporting period
- Oct 14, 2024
- Description
- Schedule 13G beneficial ownership